phase 4
study 2
idelalisib 1
entospletinib 1
pneumonitis 1
limits 2
combination 2
therapy 2
relapsed 4
refractory 5
cll 1
nhl 1
postibrutinib 1
outcomes 1
patients 5
mantle 2
cell 6
lymphoma 10
ibrutinib 3
initial 1
chronic 4
lymphocytic 4
leukemia 4
recent 1
advances 1
development 1
aurora 1
kinases 1
inhibitors 1
hematological 1
malignancies 1
rituximab 2
maintenance 3
follicular 2
trial 2
carfilzomib 1
pr 1
vorinostat 1
saha 1
bcell 4
lymphomas 1
targeting 1
b 3
receptor 1
signaling 1
diffuse 2
large 4
ii 1
intergroup 1
alisertib 1
peripheral 1
tcell 1
transformed 1
mycosis 1
fungoides 1
swog 1
bruton 1
tyrosine 1
kinase 1
inhibitor 1
chemoimmunotherapy 1
should 1
considered 1
imexon 1
prooxidant 1
molecule 1
nonhodgkin 1
infection 1
parsimony 1
has 1
crizotinib 1
salvage 1
allogeneic 1
stem 1
transplantation 1
anaplastic 1
abc 1
etiology 1
cytopenias 1
important 1
staging 1
management 1
fffuse 1
very 1
elderly 1
case 1
refining 1
clinical 1
trials 1
novel 1
agents 1
syk 1
inhibition 1
fostamatinib 1
leads 1
transitional 1
lymphocyte 1
depletion 1
getting 1
heart 1
problem 1
treating 1
